Updated Jul 16, 2026 · Last SEC filing 2026-07-02
BIODESIX INC (BDSX) has filed 1 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-02. 2 Form 8-K material event filings were reported by BDSX in the last 90 days. InsiderAlpha tracks every BDSX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Services-Medical Laboratories (SIC 8071) |
|---|---|
| SEC CIK | 0001439725 |
| Form 4 filings (90d) | 1 |
|---|---|
| Form 8-K filings (90d) | 2 |
| Latest Form 4 filing | 2026-07-02 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| PATIENCE JOHN | Insider | M — Option exercise | 1.4K | — | — | SEC | |
| PATIENCE JOHN | Insider | M — Option exercise | 1.4K | — | — | SEC | |
| Hutton Scott | President & CEO | S — Open-market sale | 1.5K | $12.78 | $19K | SEC | |
| Cowie Robin Harper | CFO, Sec'y & Treasurer | S — Open-market sale | 535 | $12.78 | $7K | SEC | |
| Pestano Gary Anthony | Chief Development Officer | S — Open-market sale | 556 | $12.78 | $7K | SEC | |
| Vazquez Chris | Chief Accounting Officer | S — Open-market sale | 211 | $12.78 | $3K | SEC | |
| O'Kane Kieran | Chief Commercial Officer | S — Open-market sale | 535 | $12.78 | $7K | SEC | |
| Hutton Scott | President & CEO | M — Option exercise | 4.8K | — | — | SEC | |
| Cowie Robin Harper | CFO, Sec'y & Treasurer | M — Option exercise | 1.5K | — | — | SEC | |
| Pestano Gary Anthony | Chief Development Officer | M — Option exercise | 1.5K | — | — | SEC | |
| Vazquez Chris | Chief Accounting Officer | M — Option exercise | 563 | — | — | SEC | |
| O'Kane Kieran | Chief Commercial Officer | M — Option exercise | 1.5K | — | — | SEC | |
| Cowie Robin Harper | CFO, Sec'y & Treasurer | S — Open-market sale | 941 | $10.08 | $9K | SEC | |
| O'Kane Kieran | Chief Commercial Officer | S — Open-market sale | 584 | $10.08 | $6K | SEC | |
| Vazquez Chris | Chief Accounting Officer | S — Open-market sale | 101 | $10.08 | $1K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for BIODESIX INC (BDSX). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| PATIENCE JOHN | 2 | — |
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in BDSX insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live BDSX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.